Full Name
Lingzhi Wang
Variants
Wang Lingzhi
Wang, L.Z.
Wang, L.-Z.
Wang, L.
 
 
 
Email
csiwl@nus.edu.sg
 
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
Type:  Article
Date Issued:  [2010 TO 2019]

Results 1-20 of 29 (Search time: 0.013 seconds).

Issue DateTitleAuthor(s)
12017A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinomaDai X.; Wang L. ; Deivasigamni A.; Looi C.Y.; Karthikeyan C.; Trivedi P.; Chinnathambi A.; Alharbi S.A.; Arfuso F.; Dharmarajan A.; Goh B.C. ; Hui K.M. ; Kumar A.P. ; Mustafa M.R.; Sethi G. 
210-Oct-2016A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activationOng, Pei-Shi ; Wang, Lingzhi ; Chia, Deborah Miao-Hui; Seah, Jolyn Yu-Xin; Kong, Li-Ren ; Thuya, Win-Lwin ; Chinnathambi, Arunachalam; Lau, Jie-Ying Amelia ; Wong, Andrea Li-Ann ; Yong, Wei-Peng ; Yang, Daiwen ; Ho, Paul Chi-Lui ; Sethi, Gautam ; Goh, Boon-Cher 
32019A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinomaZhang, M.; Wang, B.; Chong, Q.-Y. ; Pandey, V.; Guo, Z.; Chen, R.-M.; Wang, L. ; Wang, Y.; Ma, L.; Kumar, A.P. ; Zhu, T.; Wu, Z.-S.; Yin, Z.; Basappa; Goh, B.-C. ; Lobie, P.E. 
4Sep-2010A sensitive and specific liquid chromatography-tandem mass spectrometric method for determination of belinostat in plasma from liver cancer patientsWang, L.-Z. ; Chan, D.; Yeo, W.; Wan, S.-C.; Chan, S.; Chan, A.; Lee, S.-C.; Lee, H.-S.; Goh, B.-C.
52018A sensitive liquid chromatography-tandem mass spectrometry method for the determination of nimbolide in mouse serum: Application to a preclinical pharmacokinetics studyWang, L ; Khoa Phan, D.-D; Syn, N; Xiang, X; Song, H; Thuya, W.L ; Yang, S ; Wong, A.L.-A ; Kumar, A.P ; Yong, W.P ; Sethi, G ; Ho, P.C.-L ; Goh, B.C 
62018Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressorSubhash, V.V; Yeo, M.S; Wang, L ; Tan, S.H; Wong, F.Y; Thuya, W.L ; Tan, W.L; Peethala, P.C ; Soe, M.Y; Tan, D.S.P; Padmanabhan, N ; Baloglu, E; Shacham, S; Tan, P ; Koeffler, H.P ; Yong, W.P 
74-Dec-2012Combination Therapy with Gossypol Reveals Synergism against Gemcitabine Resistance in Cancer Cells with High BCL-2 ExpressionWong, F.Y.; Liem, N.; Xie, C.; Yan, F.L.; Wong, W.C.; Wang, L. ; Yong, W.-P. 
82017Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1Wang, L ; Chan, C.E.L; Wong, A.L.-A ; Wong, F.C; Lim, S.W ; Chinnathambi, A; Alharbi, S.A; Lee, L.S.-U ; Soo, R ; Yong, W.P ; Lee, S.C ; Ho, P.C.-L ; Sethi, G ; Goh, B.C 
913-Aug-2019Different treatment efficacies and side effects of cytotoxicchemotherapyWang Lingzhi ; Chong Qing Yun ; Goh Boon Cher ; Soo Ross ; Li Low-Jia
1020-Sep-2012Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research groupYeo, W.; Chung, H.C.; Chan, S.L.; Wang, L.Z. ; Lim, R.; Picus, J.; Boyer, M.; Mo, F.K.F.; Koh, J.; Rha, S.Y.; Hui, E.P.; Jeung, H.C.; Roh, J.K.; Yu, S.C.H.; To, K.F.; Tao, Q.; Ma, B.B.; Chan, A.W.H.; Tong, J.H.M.; Erlichman, C.; Chan, A.T.C.; Goh, B.C.
1117-Jun-2019FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling PathwayWang Lingzhi 
12Jul-2013Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTan, T.Z.; Miow, Q.H.; Huang, R.Y.-J.; Wong, M.K.; Ye, J.; Lau, J.A.; Wu, M.C. ; Bin Abdul Hadi, L.H.; Soong, R. ; Choolani, M.; Davidson, B.; Nesland, J.M.; Wang, L.-Z. ; Matsumura, N.; Mandai, M.; Konishi, I.; Goh, B.-C.; Chang, J.T.; Thiery, J.P. ; Mori, S. 
132015Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkersLi F. ; Shanmugam M.K. ; Siveen K.S. ; Wang F. ; Ong T.H.; Loo S.Y. ; Swamy M.M.M.; Mandal S.; Kumar A.P. ; Goh B.C. ; Kundu T.; Ahn K.S.; Wang L.Z. ; Hui K.M. ; Sethi G. 
1430-Jan-2013Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer PatientsWang, L.-Z. ; Ramírez, J.; Yeo, W.; Chan, M.-Y.M.; Thuya, W.-L. ; Lau, J.-Y.A.; Wan, S.-C.; Wong, A.L.-A.; Zee, Y.-K.; Lim, R.; Lee, S.-C. ; Ho, P.C. ; Lee, H.-S.; Chan, A.; Ansher, S.; Ratain, M.J.; Goh, B.-C.
153-Aug-2012Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKLWen, Q.; Goldenson, B.; Silver, S.J.; Schenone, M.; Dancik, V.; Huang, Z.; Wang, L.-Z. ; Lewis, T.A.; An, W.F.; Li, X.; Bray, M.-A.; Thiollier, C.; Diebold, L.; Gilles, L.; Vokes, M.S.; Moore, C.B.; Bliss-Moreau, M.; Verplank, L.; Tolliday, N.J.; Mishra, R.; Vemula, S.; Shi, J.; Wei, L.; Kapur, R.; Lopez, C.K.; Gerby, B.; Ballerini, P.; Pflumio, F.; Gilliland, D.G.; Goldberg, L.; Birger, Y.; Izraeli, S.; Gamis, A.S.; Smith, F.O.; Woods, W.G.; Taub, J.; Scherer, C.A.; Bradner, J.E.; Goh, B.-C.; Mercher, T.; Carpenter, A.E.; Gould, R.J.; Clemons, P.A.; Carr, S.A.; Root, D.E.; Schreiber, S.L.; Stern, A.M.; Crispino, J.D.
165-Dec-2019MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphomaLi, Boheng ; Yan, Junli ; The, Phyu; Fan, Shuangyi ; Chung, Tae-Hoon; Mustafa, Nurulhuda; Lin, Baohong; Wang, Lingzhi ; Eichhorn, Pieter Johan Adam; Goh, Boon-Cher ; Ng, Siok-Bian ; Kappei, Dennis; Chng, Wee-Joo 
175-Mar-2012Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometryWang, L.-Z. ; Ong, R.Y.-L.; Chin, T.-M. ; Thuya, W.-L. ; Wan, S.-C.; Wong, A.L.A.; Chan, S.-Y. ; Ho, P.C. ; Goh, B.-C.
182015Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patientsDai X.; Ahn K.S.; Kim C.; Siveen K.S. ; Ong T.H.; Shanmugam M.K. ; Li F.; Shi J. ; ALAN PREM KUMAR ; Wang L.Z. ; Goh B.C. ; Magae J.; Hui K.M.; Sethi G. 
192017Non-malignant epithelial cells preferentially proliferate from nasopharyngeal carcinoma biopsy cultured under conditionally reprogrammed conditionsYu F. ; Lu Y.; Tao L. ; Jiang Y.-Y. ; Lin D.-C.; Wang L. ; Petersson F. ; Yoshiyama H.; Koeffler P.H.; Goh B.-C. ; Loh K.S. 
202018Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft modelsSyn N.L.; Lim P.L.; Kong L.R.; Wang L. ; Wong A.L.-A. ; Lim C.M. ; Loh T.K.S. ; Siemeister G.; Goh B.C. ; Hsieh W.-S.